Načítá se...

The Safety and Efficacy of Apatinib Treatment in Addition to Concurrent Chemoradiotherapy in Patients with Nonoperative Locally Advanced Esophageal Squamous Cell Carcinoma

BACKGROUND: Esophageal cancer is a common gastrointestinal malignancy in China. We evaluated the efficacy and safety of adding Apatinib to concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma. MATERIAL/METHODS: In this single-center retrospective study, w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Med Sci Monit
Hlavní autoři: Hu, Lijun, Kong, Ze, Meng, Qinghong, Wang, Jianlin, Zhou, Mengyun, Yu, Jingping, Jiang, Xiaodong
Médium: Artigo
Jazyk:Inglês
Vydáno: International Scientific Literature, Inc. 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7706142/
https://ncbi.nlm.nih.gov/pubmed/33243967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.927221
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!